Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Childhood Soft Tissue Sarcoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information

Table 1. Age Distribution of Soft Tissue Sarcomas (STSs) in Children Aged 0 to 19 Years (SEER 1975–2008)

Age <5 yAge 5–9 yAge 10–14 yAge 15–19 y% of the Total Number of STS Cases <20 y
pPNET = peripheral primitive neuroectodermal tumors; SEER = Surveillance Epidemiology and End Results.
a Dermatofibrosarcoma accounts for 75% of these cases.
All soft tissue and other extraosseous sarcomas1,1308101,1441,573 100
 
Rhabdomyosarcomas71046636435041
Fibrosarcomas, peripheral nerve, and other fibrous neoplasms15164132 19212
 Fibroblastic and myofibroblastic tumors131315786 6.5
 Nerve sheath tumors193274104 5
 Other fibromatous neoplasms1112 0.1
Kaposi sarcoma120 12 0.3
Other specified soft tissue sarcomas19822051285638
 Ewing tumor and Askin tumor of soft tissue22285781 4
 pPNET of soft tissue21192942 2.4
 Extrarenal rhabdoid tumor37383 1
 Liposarcomas562266 2
 Fibrohistiocytic tumorsa5369171293 12
 Leiomyosarcomas13192257 2.4
 Synovial sarcomas1239133204 8.3
 Blood vessel tumors1571133 1.4
 Osseous and chondromatous neoplasms of soft tissue15916 0.6
 Alveolar soft parts sarcoma371926 1
 Miscellaneous soft tissue sarcomas16183135 2
Unspecified soft tissue sarcomas7058136 1639


cdr0000741846.jpg
Figure 1. The distribution of nonrhabdomyosarcomatous soft tissue sarcomas in children aged 0 to 19 years, as reported by the Surveillance Epidemiology and End Results program from 1975 to 2008.

Nonrhabdomyosarcomatous STSs are more common in adolescents and adults,[6] and most of the information regarding treatment and natural history of the disease in younger patients has been based on adult studies.

Risk Factors

Some genetic and environmental factors have been associated with the development of nonrhabdomyosarcomatous STS:

  • Genetic factors:
    • Li-Fraumeni syndrome: Patients with Li-Fraumeni syndrome (usually due to heritable cancer-associated changes of the p53 tumor suppressor gene) have an increased risk of developing soft tissue tumors (mostly nonrhabdomyosarcomatous STSs), bone sarcomas, breast cancer, brain tumors, and acute leukemia.[5,9]
    • Neurofibromatosis type 1: Approximately 4% of patients with neurofibromatosis type 1 develop malignant peripheral nerve sheath tumors, which usually develop after a long latency; some patients develop multiple lesions.[10,11,12]
    • Familial adenomatous polyposis: Patients with familial adenomatous polyposis are at increased risk of developing desmoid tumors.[13]
    • Werner syndrome: Werner syndrome is characterized by spontaneous chromosomal instability, resulting in increased susceptibility to cancer and premature aging. An excess of STSs has been reported in patients with Werner syndrome.[14]
    • Retinoblastoma gene: Germline mutations of the retinoblastoma gene have been associated with an increased risk of developing STSs, particularly leiomyosarcoma.[15]
  • Environmental factors:
    • Radiation: Some nonrhabdomyosarcomatous STSs (particularly malignant fibrous histiocytoma) can develop within a previously irradiated site.[5,16]
    • Epstein-Barr virus infection in patients with AIDS: Some nonrhabdomyosarcomatous STSs (e.g., leiomyosarcoma) have been linked to Epstein-Barr virus infection in patients with AIDS.[5,17]
1|2|3|4|5

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article